Recovery of Lymphocyte and Dendritic Cell Subsets Following Reduced Intensity Allogeneic Bone Marrow Transplantation

References

• Horowitz, M.M., Gale, R.P., Sondel, P.M., et al. (1990) "Graft-versus-leukemia reactions after bone marrow transplan-tation", Blood 75, 555–562.
   PubMed Web of Science ®Google Scholar
• Maraninchi, D., Gluckman, E., Blaise, D., et al. (1987) "Impact of T-cell depletion on outcome of allogeneic bone-marrow transplantation for standard-risk leukaemias", Lancet 2, 175–178.
   PubMed Web of Science ®Google Scholar
• Gale, R.P., Horowitz, M.M., Ash, R.C., et al. (1994) "Identical-twin bone marrow transplants for leukemia", Ann. Intern. Med. 120, 646–652.
   PubMed Web of Science ®Google Scholar
• Kolb, H.J., Schattenberg, A., Goldman, J.M., et al. (1995) "Graft-versus-leukemia effect of donor lymphocyte transfu-sions in marrow grafted patients. European group for blood and marrow transplantation working party chronic leuke-mia", Blood 86, 2041–2050.
   PubMed Web of Science ®Google Scholar
• Slavin, S., Nagler, A., Naparstek, E., et al. (1998) "Non-myeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases", Blood 91, 756–763.
   PubMed Web of Science ®Google Scholar
• Giralt, S., Estey, E., Albitar, M., et al. (1997) "Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: harnessing graft-versus-leukemia without myeloablative therapy", Blood 89, 4531–4536.
   PubMed Web of Science ®Google Scholar
• Morecki, S., Gelfand, Y., Nagler, A., et al. (2001) "Immune reconstitution following allogeneic stem cell transplantation in recipients conditioned by low intensity vs myeloablative regimen", Bone Marrow Transplant. 28, 243–249.
   PubMed Web of Science ®Google Scholar
• Savage, W.J., Bleesing, J.J., Douek, D., et al. (2001) "Lymphocyte reconstitution following non-myeloablative hematopoietic stem cell transplantation follows two patterns depending on age and donor/recipient chimerism", Bone Marrow Transplant. 28, 463–471.
   PubMed Web of Science ®Google Scholar
• Mohty, M., Faucher, C., Vey, N., et al. (2000) "High rate of secondary viral and bacterial infections in patients under-going allogeneic bone marrow mini-transplantation", Bone Marrow Transplant. 26, 251–255.
   PubMed Web of Science ®Google Scholar
• Blaise, D., Kuentz, M., Fortanier, C., et al. (2000) "Randomized trial of bone marrow versus lenograstim-primed blood cell allogeneic transplantation in patients with early-stage leukemia: a report from the Societe Francaise de Greffe de Moelle", J. Clin. Oncol. 18, 537–546.
   PubMed Web of Science ®Google Scholar
• Mohty, M., Jarrossay, D., Lafage-Pochitaloff, M., et al. (2001) "Circulating blood dendritic cells from myeloid leukemia patients display quantitative and cytogenetic abnormalities as well as functional impairment", Blood 98, 3750–3756.
   PubMed Web of Science ®Google Scholar
• Banchereau, J. and Steinman, R.M. (1998) "Dendritic cells and the control of immunity", Nature 392, 245–252.
   PubMed Web of Science ®Google Scholar
• Banchereau, J., Briere, F., Caux, C., et al. (2000) "Immuno-biology of dendritic cells", Annu. Rev. Immunol. 18, 767–811.
   PubMed Web of Science ®Google Scholar
• Fearnley, D.B., Whyte, L.F., Carnoutsos, S.A., Cook, A.H. and Hart, D.N. (1999) "Monitoring human blood dendritic cell numbers in normal individuals and in stem cell transplan-tation", Blood. 93, 728–736.
   PubMed Web of Science ®Google Scholar
• Cella, M., Jarrossay, D., Facchetti, F., et al. (1999) "Plasmacy-toid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon", Nat. Med. 5, 919–923.
   PubMed Web of Science ®Google Scholar
• Savary, C.A., Grazziutti, M.L., Melichar, B., et al. (1998) "Multidimensional flow-cytometric analysis of dendritic cells in peripheral blood of normal donors and cancer patients", Cancer Immunol. Immunother. 45, 234–240.
   PubMed Web of Science ®Google Scholar
• Witherspoon, R.P., Lum, L.G. and Storb, R. (1984) "Immuno-logic reconstitution after human marrow grafting", Semin. Hematol. 21, 2–10.
   PubMed Web of Science ®Google Scholar
• Small, T.N. (1996) "Immunologic reconstitution following stem cell transplantation", Curr. Opin. Hematol. 3, 461–465.
   PubMedGoogle Scholar
• Storek, J., Witherspoon, R.P. and Storb, R. (1995) "T cell reconstitution after bone marrow transplantation into adult patients does not resemble T cell development in early life", Bone Marrow Transplant. 16, 413–425.
   PubMed Web of Science ®Google Scholar
• Heitger, A., Neu, N., Kern, H., et al. (1997) "Essential role of the thymus to reconstitute naive (CD45RA +) T-helper cells after human allogeneic bone marrow transplantation", Blood 90, 850–857.
   PubMed Web of Science ®Google Scholar
• Small, T.N., Papadopoulos, E.B., Boulad, F., et al. (1999) "Comparison of immune reconstitution after unrelated and related T-cell-depleted bone marrow transplantation: effect of patient age and donor leukocyte infusions", Blood 93, 467–480.
   PubMed Web of Science ®Google Scholar
• Dulude, G., Brochu, S., Fontaine, P., et al. (1997) "Thymic and extrathymic differentiation and expansion of T lymphocytes following bone marrow transplantation in irradiated reci-pients", Exp. Hematol. 25, 992–1004.
   PubMed Web of Science ®Google Scholar
• Mackall, C.L., Fleisher, T.A., Brown, M.R., et al. (1995) "Age, thymopoiesis, and CD4 T-lymphocyte regeneration after intensive chemotherapy", N. Engl. J. Med. 332, 143–149.
   PubMed Web of Science ®Google Scholar
• Mohty, M., Fegueux, N., Exbrayat, C., et al. (2001) "Enhanced graft-versus-tumor effect following dose-reduced condition-ing and allogeneic transplantation for refractory lymphoid malignancies after high-dose therapy", Bone Marrow Trans-plant. 28, 335–339.
   PubMed Web of Science ®Google Scholar
• Bathos, A., Barlogie, B., Morris, C., et al. (2001) "High response rate in refractory and poor-risk multiple myeloma after allotransplantation using a nonmyeloablative conditioning regimen and donor lymphocyte infusions", Blood 97, 2574–2579.
   PubMed Web of Science ®Google Scholar
• Rocha, B., Vassalli, P. and Guy-Grand, D. (1994) "Thymic and extrathymic origins of gut intraepithelial lymphocyte populations in mice", J. Exp. Med. 180, 681–686.
   PubMed Web of Science ®Google Scholar
• Keating, M.J., Kantarjian, H., Talpaz, M., et al. (1989) "Fludarabine: a new agent with major activity against chronic lymphocytic leukemia", Blood 74, 19–25.
   PubMed Web of Science ®Google Scholar
• Small, T.N., Avigan, D., Dupont, B., et al. (1997) "Immune reconstitution following T-cell depleted bone marrow trans-plantation: effect of age and posttransplant graft rejection prophylaxis", Biol. Blood Marrow Transplant. 3, 65–75.
   PubMedGoogle Scholar
• Rissoan, M.C., Soumelis, V., Kadowaki, N., et al. (1999) "Reciprocal control of T helper cell and dendritic cell differentiation", Science 283, 1183–1186.
   PubMed Web of Science ®Google Scholar
• Siegal, F.P., Kadowaki, N., Shodell, M., et al. (1999) "The nature of the principal type 1 interferon-producing cells in human blood", Science 284, 1835–1837.
   PubMed Web of Science ®Google Scholar
• Pfeffer, L.M., Dinarello, C.A., Herberman, R.B., et al. (1998) "Biological properties of recombinant alpha-interferons: 40th anniversary of the discovery of interferons", Cancer Res. 58, 2489–2499.
   PubMed Web of Science ®Google Scholar
• Sun, S., Zhang, X., Tough, D.F. and Sprent, J. (1998) "Type I interferon-mediated stimulation of T cells by CpG DNA", J. Exp. Med. 188, 2335–2342.
   PubMed Web of Science ®Google Scholar
• Marrack, P., Kappler, J. and Mitchell, T. (1999) "Type I interferons keep activated T cells alive", J. Exp. Med. 189, 521–530.
   PubMed Web of Science ®Google Scholar
• Kayagaki, N., Yamaguchi, N., Nakayama, M., Eto, H., Okumura, K. and Yagita, H. (1999) "Type I interferons (IENs) regulate tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) expression on human T cells: A novel mechanism for the antitumor effects of type I IFNs", J. Exp. Med. 189, 1451–1460.
   PubMed Web of Science ®Google Scholar
• Shlomchik, W.D., Couzens, MS., Tang, C.B., et al. (1999) "Prevention of graft versus host disease by inactivation of host antigen-presenting cells", Science 285, 412–415.
   PubMed Web of Science ®Google Scholar
• Behbahani, H., Landay, A., Patterson, B.K., et al. (2000) "Normalization of immune activation in lymphoid tissue following highly active antiretroviral therapy", J. Acquir. Immune Defic. Syndr. 25, 150–156.
   PubMed Web of Science ®Google Scholar